Literature DB >> 25315681

PARK2 patient neuroprogenitors show increased mitochondrial sensitivity to copper.

Asad A Aboud1, Andrew M Tidball1, Kevin K Kumar1, M Diana Neely2, Bingying Han3, Kevin C Ess4, Charles C Hong5, Keith M Erikson6, Peter Hedera7, Aaron B Bowman8.   

Abstract

Poorly-defined interactions between environmental and genetic risk factors underlie Parkinson's disease (PD) etiology. Here we tested the hypothesis that human stem cell derived forebrain neuroprogenitors from patients with known familial risk for early onset PD will exhibit enhanced sensitivity to PD environmental risk factors compared to healthy control subjects without a family history of PD. Two male siblings (SM and PM) with biallelic loss-of-function mutations in PARK2 were identified. Human induced pluripotent stem cells (hiPSCs) from SM, PM, and four control subjects with no known family histories of PD or related neurodegenerative diseases were utilized. We tested the hypothesis that hiPSC-derived neuroprogenitors from patients with PARK2 mutations would show heightened cell death, mitochondrial dysfunction, and reactive oxygen species generation compared to control cells as a result of exposure to heavy metals (PD environmental risk factors). We report that PARK2 mutant neuroprogenitors showed increased cytotoxicity with copper (Cu) and cadmium (Cd) exposure but not manganese (Mn) or methyl mercury (MeHg) relative to control neuroprogenitors. PARK2 mutant neuroprogenitors also showed a substantial increase in mitochondrial fragmentation, initial ROS generation, and loss of mitochondrial membrane potential following Cu exposure. Our data substantiate Cu exposure as an environmental risk factor for PD. Furthermore, we report a shift in the lowest observable effect level (LOEL) for greater sensitivity to Cu-dependent mitochondrial dysfunction in patients SM and PM relative to controls, correlating with their increased genetic risk for PD.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Copper; Environmental risk factors; Neurotoxicty; PARK2; Parkinson's disease

Mesh:

Substances:

Year:  2014        PMID: 25315681      PMCID: PMC4394022          DOI: 10.1016/j.nbd.2014.10.002

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  51 in total

1.  Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease.

Authors:  J M Gorell; C C Johnson; B A Rybicki; E L Peterson; G X Kortsha; G G Brown; R J Richardson
Journal:  Neurotoxicology       Date:  1999 Apr-Jun       Impact factor: 4.294

2.  Disease-toxicant screen reveals a neuroprotective interaction between Huntington's disease and manganese exposure.

Authors:  B Blairanne Williams; Daphne Li; Michal Wegrzynowicz; Bhavin K Vadodaria; Joel G Anderson; Gunnar F Kwakye; Michael Aschner; Keith M Erikson; Aaron B Bowman
Journal:  J Neurochem       Date:  2009-10-21       Impact factor: 5.372

3.  A more efficient method to generate integration-free human iPS cells.

Authors:  Keisuke Okita; Yasuko Matsumura; Yoshiko Sato; Aki Okada; Asuka Morizane; Satoshi Okamoto; Hyenjong Hong; Masato Nakagawa; Koji Tanabe; Ken-ichi Tezuka; Toshiyuki Shibata; Takahiro Kunisada; Masayo Takahashi; Jun Takahashi; Hiroh Saji; Shinya Yamanaka
Journal:  Nat Methods       Date:  2011-04-03       Impact factor: 28.547

4.  Evidence for environmental causation of Parkinson's disease.

Authors:  Raúl de la Fuente-Fernández; Donald B Calne
Journal:  Parkinsonism Relat Disord       Date:  2002-03       Impact factor: 4.891

Review 5.  The transition metals copper and iron in neurodegenerative diseases.

Authors:  Susana Rivera-Mancía; Iván Pérez-Neri; Camilo Ríos; Luis Tristán-López; Liliana Rivera-Espinosa; Sergio Montes
Journal:  Chem Biol Interact       Date:  2010-05-14       Impact factor: 5.192

6.  NAD(H) enhances the Cu(II)-mediated inactivation of lactate dehydrogenase by increasing the accessibility of sulfhydryl groups.

Authors:  K Pamp; T Bramey; M Kirsch; H De Groot; F Petrat
Journal:  Free Radic Res       Date:  2005-01

7.  Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease.

Authors:  Adriana Sánchez-Danés; Yvonne Richaud-Patin; Iria Carballo-Carbajal; Senda Jiménez-Delgado; Carles Caig; Sergio Mora; Claudia Di Guglielmo; Mario Ezquerra; Bindiben Patel; Albert Giralt; Josep M Canals; Maurizio Memo; Jordi Alberch; José López-Barneo; Miquel Vila; Ana Maria Cuervo; Eduard Tolosa; Antonella Consiglio; Angel Raya
Journal:  EMBO Mol Med       Date:  2012-03-08       Impact factor: 12.137

8.  Zn²⁺ dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation.

Authors:  Taiji Tsunemi; Dimitri Krainc
Journal:  Hum Mol Genet       Date:  2013-12-13       Impact factor: 5.121

Review 9.  Silent latency periods in methylmercury poisoning and in neurodegenerative disease.

Authors:  Bernard Weiss; Thomas W Clarkson; William Simon
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

10.  Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue.

Authors:  Yoichi Imaizumi; Yohei Okada; Wado Akamatsu; Masato Koike; Naoko Kuzumaki; Hideki Hayakawa; Tomoko Nihira; Tetsuro Kobayashi; Manabu Ohyama; Shigeto Sato; Masashi Takanashi; Manabu Funayama; Akiyoshi Hirayama; Tomoyoshi Soga; Takako Hishiki; Makoto Suematsu; Takuya Yagi; Daisuke Ito; Arifumi Kosakai; Kozo Hayashi; Masanobu Shouji; Atsushi Nakanishi; Norihiro Suzuki; Yoshikuni Mizuno; Noboru Mizushima; Masayuki Amagai; Yasuo Uchiyama; Hideki Mochizuki; Nobutaka Hattori; Hideyuki Okano
Journal:  Mol Brain       Date:  2012-10-06       Impact factor: 4.041

View more
  30 in total

1.  Differential responses of induced pluripotent stem cell-derived cardiomyocytes to anisotropic strain depends on disease status.

Authors:  Young Wook Chun; David E Voyles; Rutwik Rath; Lucas H Hofmeister; Timothy C Boire; Henry Wilcox; Jae Han Lee; Leon M Bellan; Charles C Hong; Hak-Joon Sung
Journal:  J Biomech       Date:  2015-10-08       Impact factor: 2.712

Review 2.  Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases.

Authors:  Shivani Ghaisas; Joshua Maher; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2015-11-26       Impact factor: 12.310

3.  Fully automated software for quantitative measurements of mitochondrial morphology.

Authors:  P Mason McClatchey; Amy C Keller; Ron Bouchard; Leslie A Knaub; Jane E B Reusch
Journal:  Mitochondrion       Date:  2015-12-11       Impact factor: 4.160

Review 4.  Neurotoxicity Linked to Dysfunctional Metal Ion Homeostasis and Xenobiotic Metal Exposure: Redox Signaling and Oxidative Stress.

Authors:  Carla Garza-Lombó; Yanahi Posadas; Liliana Quintanar; María E Gonsebatt; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2018-03-28       Impact factor: 8.401

Review 5.  Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases.

Authors:  Xinwen Zhang; Di Hu; Yutong Shang; Xin Qi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-03-18       Impact factor: 5.187

Review 6.  Genetic predispositions of Parkinson's disease revealed in patient-derived brain cells.

Authors:  Jenne Tran; Helena Anastacio; Cedric Bardy
Journal:  NPJ Parkinsons Dis       Date:  2020-04-24

Review 7.  The Endolysosomal System and Proteostasis: From Development to Degeneration.

Authors:  Bettina Winckler; Victor Faundez; Sandra Maday; Qian Cai; Cláudia Guimas Almeida; Huaye Zhang
Journal:  J Neurosci       Date:  2018-10-31       Impact factor: 6.167

8.  Loss of pdr-1/parkin influences Mn homeostasis through altered ferroportin expression in C. elegans.

Authors:  Sudipta Chakraborty; Pan Chen; Julia Bornhorst; Tanja Schwerdtle; Fabian Schumacher; Burkhard Kleuser; Aaron B Bowman; Michael Aschner
Journal:  Metallomics       Date:  2015-03-13       Impact factor: 4.526

Review 9.  Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes.

Authors:  S L Sison; S C Vermilyea; M E Emborg; A D Ebert
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-04       Impact factor: 5.081

10.  Recreating blood-brain barrier physiology and structure on chip: A novel neurovascular microfluidic bioreactor.

Authors:  Jacquelyn A Brown; Virginia Pensabene; Dmitry A Markov; Vanessa Allwardt; M Diana Neely; Mingjian Shi; Clayton M Britt; Orlando S Hoilett; Qing Yang; Bryson M Brewer; Philip C Samson; Lisa J McCawley; James M May; Donna J Webb; Deyu Li; Aaron B Bowman; Ronald S Reiserer; John P Wikswo
Journal:  Biomicrofluidics       Date:  2015-10-26       Impact factor: 2.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.